Sensei Biotherapeutics Crescita futura
Future criteri di controllo 0/6
Sensei Biotherapeutics's earnings are forecast to decline at 18.9% per annum. EPS is expected to decline by 1.9% per annum.
Informazioni chiave
-18.9%
Tasso di crescita degli utili
-1.9%
Tasso di crescita dell'EPS
Biotechs crescita degli utili | 27.1% |
Tasso di crescita dei ricavi | n/a |
Rendimento futuro del capitale proprio | -59.8% |
Copertura analitica | Low |
Ultimo aggiornamento | 03 Oct 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Is Sensei Biotherapeutics (NASDAQ:SNSE) In A Good Position To Deliver On Growth Plans?
Nov 03We Think Sensei Biotherapeutics (NASDAQ:SNSE) Needs To Drive Business Growth Carefully
Jul 02Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Mar 14We're Hopeful That Sensei Biotherapeutics (NASDAQ:SNSE) Will Use Its Cash Wisely
Aug 14Sensei Biotherapeutics GAAP EPS of -$0.34 beats by $0.06
Aug 09Here's Why We're Watching Sensei Biotherapeutics' (NASDAQ:SNSE) Cash Burn Situation
Apr 18Sensei Biotherapeutics (NASDAQ:SNSE) Is In A Good Position To Deliver On Growth Plans
Nov 16Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | N/A | -44 | N/A | -49 | 2 |
12/31/2025 | N/A | -37 | N/A | -40 | 2 |
12/31/2024 | N/A | -31 | N/A | -32 | 3 |
6/30/2024 | N/A | -30 | -24 | -24 | N/A |
3/31/2024 | N/A | -32 | -28 | -28 | N/A |
12/31/2023 | N/A | -34 | -32 | -32 | N/A |
9/30/2023 | N/A | -39 | -36 | -35 | N/A |
6/30/2023 | N/A | -45 | -38 | -38 | N/A |
3/31/2023 | N/A | -46 | -40 | -40 | N/A |
12/31/2022 | N/A | -49 | -39 | -39 | N/A |
9/30/2022 | N/A | -46 | -38 | -37 | N/A |
6/30/2022 | N/A | -42 | -37 | -36 | N/A |
3/31/2022 | N/A | -41 | -32 | -30 | N/A |
12/31/2021 | N/A | -37 | -32 | -30 | N/A |
9/30/2021 | N/A | -33 | -27 | -25 | N/A |
6/30/2021 | N/A | -28 | -28 | -25 | N/A |
3/31/2021 | N/A | -23 | -24 | -22 | N/A |
12/31/2020 | N/A | -20 | -19 | -18 | N/A |
9/30/2020 | N/A | -23 | -18 | -17 | N/A |
12/31/2019 | N/A | -21 | -9 | -9 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: SNSE is forecast to remain unprofitable over the next 3 years.
Guadagni vs Mercato: SNSE is forecast to remain unprofitable over the next 3 years.
Guadagni ad alta crescita: SNSE is forecast to remain unprofitable over the next 3 years.
Ricavi vs Mercato: Insufficient data to determine if SNSE's revenue is forecast to grow faster than the US market.
Ricavi ad alta crescita: SNSE is forecast to have no revenue next year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: SNSE is forecast to be unprofitable in 3 years.